Lactones: Generic Inhibitors of Enzymes?

Title: Lactones: Generic Inhibitors of Enzymes?

Volume: 5 Issue: 1

Author(s): Monika I. Konaklieva and Balbina J. Plotkin

Affiliation:

Keywords: lactones, dna polymerases, human immunodeficiency virus type 1 (hiv-1) reverse transcriptase, cytokines

Abstract: The ability to affect eukaryotic and prokaryotic cellular growth, signaling and differentiation is a continuing focus in the pharmaceutical industry. The fundamental ability to affect these cellular processes is inherent in lactones. Lactones, which are ubiquitous in nature, reflect a broad phylogenetic diversity indicative of their ability to act as simple alkylating compounds, with their in situ activities falling into one of two categories, i.e., protect or conquer. Medically, their utility as pharmaceutical agents range from that of antimicrobial to anti-neoplastic agent depending on the functional groups attached.

Cite this article as:

Konaklieva I. Monika and Plotkin J. Balbina, Lactones: Generic Inhibitors of Enzymes?, Mini-Reviews in Medicinal Chemistry 2005; 5 (1) . https://dx.doi.org/10.2174/1389557053402828